Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases

NCT06480630 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

39

Enrollment

OTHER_GOV

Sponsor class

Conditions

Acute Graft Versus Host Disease
Malignant Hematologic Neoplasm

Interventions

DRUG: Basiliximab

Sponsor

Anhui Provincial Hospital